409 related articles for article (PubMed ID: 15660575)
1. Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg?
Himmelfarb J
Semin Dial; 2004; 17(6):449-54. PubMed ID: 15660575
[TBL] [Abstract][Full Text] [Related]
2. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.
Himmelfarb J
Semin Dial; 2009; 22(6):636-43. PubMed ID: 20017834
[TBL] [Abstract][Full Text] [Related]
3. Relevance of oxidative pathways in the pathophysiology of chronic kidney disease.
Himmelfarb J
Cardiol Clin; 2005 Aug; 23(3):319-30. PubMed ID: 16084281
[TBL] [Abstract][Full Text] [Related]
4. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
[TBL] [Abstract][Full Text] [Related]
5. Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease.
Stenvinkel P
J Ren Nutr; 2003 Apr; 13(2):144-8. PubMed ID: 12671839
[TBL] [Abstract][Full Text] [Related]
6. [Oxidative stress in chronic renal failure and hemodialysis].
Descamps-Latscha B; Witko-Sarsat V
Nephrologie; 2003; 24(7):377-9. PubMed ID: 14650750
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and insulin resistance in uremia.
Zanetti M; Barazzoni R; Guarnieri G
J Ren Nutr; 2008 Jan; 18(1):70-5. PubMed ID: 18089448
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.
Maruyama Y; Lindholm B; Stenvinkel P
J Nephrol; 2004; 17 Suppl 8():S72-6. PubMed ID: 15599890
[TBL] [Abstract][Full Text] [Related]
9. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
[TBL] [Abstract][Full Text] [Related]
10. [Malnutrition -- inflammation -- atherosclerosis (MIA syndrome) in patients with renal failure].
Pawlaczyk K; Oko A; Lindholm B; Czekalski S
Pol Merkur Lekarski; 2003 Oct; 15(88):334-41; discussion 341-3. PubMed ID: 14974361
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure.
Cottone S; Lorito MC; Riccobene R; Nardi E; Mulè G; Buscemi S; Geraci C; Guarneri M; Arsena R; Cerasola G
J Nephrol; 2008; 21(2):175-9. PubMed ID: 18446711
[TBL] [Abstract][Full Text] [Related]
12. [Effect of oxidative stress in patients with chronic renal failure].
González Rico M; Puchades MJ; García Ramón R; Saez G; Tormos MC; Miguel A
Nefrologia; 2006; 26(2):218-25. PubMed ID: 16808260
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant therapy in uremia: evidence-based medicine?
Gordon CA; Himmelfarb J
Semin Dial; 2004; 17(5):327-32. PubMed ID: 15461735
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress: an accomplice to uremic toxicity?
Mircescu G
J Ren Nutr; 2006 Jul; 16(3):194-8. PubMed ID: 16825018
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress and inflammation: Implications in uremia and hemodialysis.
Libetta C; Sepe V; Esposito P; Galli F; Dal Canton A
Clin Biochem; 2011 Oct; 44(14-15):1189-98. PubMed ID: 21777574
[TBL] [Abstract][Full Text] [Related]
16. Intravenous iron, inflammation, and oxidative stress: is iron a friend or an enemy of uremic patients?
Garneata L
J Ren Nutr; 2008 Jan; 18(1):40-5. PubMed ID: 18089442
[TBL] [Abstract][Full Text] [Related]
17. End-stage renal disease--not an equal opportunity disease: the role of genetic polymorphisms.
Nordfors L; Lindholm B; Stenvinkel P
J Intern Med; 2005 Jul; 258(1):1-12. PubMed ID: 15953127
[TBL] [Abstract][Full Text] [Related]
18. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation.
Morena M; Delbosc S; Dupuy AM; Canaud B; Cristol JP
Hemodial Int; 2005 Jan; 9(1):37-46. PubMed ID: 16191052
[TBL] [Abstract][Full Text] [Related]
19. Special characteristics of atherosclerosis in chronic renal failure.
Amann K; Tyralla K; Gross ML; Eifert T; Adamczak M; Ritz E
Clin Nephrol; 2003 Jul; 60 Suppl 1():S13-21. PubMed ID: 12940530
[TBL] [Abstract][Full Text] [Related]
20. [Inflammation, oxidative stress and kidney function in arterial hypertension].
Cerasola G; Guarneri M; Cottone S
G Ital Nefrol; 2009; 26 Suppl 46():8-13. PubMed ID: 19644813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
